Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL237187 | 0.85 | TSHR (0.49) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL143881 | 0.85 | THRB (0.48) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL80190 | 0.82 | THRB (0.50) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL332509 | 0.82 | TSHR (0.47) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL7190871 | 0.82 | TSHR (0.47) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL16537817 | 0.81 | THRB (0.46) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL340146 | 0.81 | THRB (0.55) | THRBTSHRALDH1A1LMNAHSD17B10 | |
| SCHEMBL231313 | 0.80 | ALDH1A1 (0.42) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL229519 | 0.80 | TSHR (0.45) | THRBTSHRALDH1A1POLBAPEX1 | |
| SCHEMBL28561857 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 845 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049202-A1 | SILANE COMPOUND AND COMPOSITIONS CONTAINING SAME | SYNTHOMER SDN BHD (MY) | 2026-02-19 | — | — | US | claimed |
| EP-4619470-A1 | SILANE COMPOUND AND COMPOSITIONS CONTAINING SAME | Synthomer Sdn. Bhd. (MY) | 2025-09-24 | — | — | EP | claimed |
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| CN-120202247-A | Silane compound and composition containing same | 昕特玛私人有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-20250109153-A1 | A novel meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| WO-2024107042-A1 | SILANE COMPOUND AND COMPOSITIONS CONTAINING SAME | SYNTHOMER SDN BHD (MY) | 2024-05-23 | — | — | WO | claimed |
| US-11975125-B2 | Medical devices | MICROVENTION, INC. (US) | 2024-05-07 | — | — | US | claimed |
| EP-3860669-B1 | MEDICAL DEVICES | MICROVENTION INC (US) | 2024-04-03 | — | — | EP | claimed |
| US-20240093058-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | MERCK PATENT GMBH (DE) | 2024-03-21 | — | — | US | claimed |
| EP-4274866-A1 | POLYSILAZANE HARD COATING COMPOSITIONS | Merck Patent GmbH (DE) | 2023-11-15 | — | — | EP | claimed |
| WO-2005124792-A1 | ANTI-CORROSION ADDITIVE FOR ELECTRICAL CABLE RESTORATION FLUIDS | DOW CORNING CORPORATION (US) | 2005-12-29 | — | — | WO | claimed |
| US-6841694-B2 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2005-01-11 | — | — | US | claimed |
| EP-1469002-A1 | Method for stabilizing unsaturated organo-silicon compounds | Wacker-Chemie GmbH (DE) | 2004-10-20 | — | — | EP | claimed |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | WACKER-CHEMIE GMBH (DE) | 2004-09-02 | — | — | US | claimed |
| US-6699935-B2 | A CROSSLINKED RUBBER PARTICLES CONTAINING CONJUGATED DIENE MONOMER, AROMATIC VINYL MONOMER AND MONOMER WITH AT LEAST TWO POLYMERIZABLE UNSATURATED GROUPS DISPERSED IN A CONJUGATED DIENE/AROMATIC VINYL COPOLYMER; RESIST TO ROLLING, SKID, WEAR | JSR CORPORATION (JP) | 2004-03-02 | — | — | US | claimed |
| US-6653404-B2 | Melt processability; dimensional stability | JSR CORPORATION (JP) | 2003-11-25 | — | — | US | claimed |
| US-20030125467-A1 | A crosslinked rubber particles containing conjugated diene monomer, aromatic vinyl monomer and monomer with at least two polymerizable unsaturated groups dispersed in a conjugated diene/aromatic vinyl copolymer; resist to rolling, skid, wear | JSR CORPORATION (JP) | 2003-07-03 | — | — | US | claimed |
| EP-1298166-A1 | RUBBER COMPOSITION | JSR Corporation (JP) | 2003-04-02 | — | — | EP | claimed |
| US-20010053813-A1 | Rubber compositions | JSR CORPORATION (JP) | 2001-12-20 | — | — | US | claimed |
| US-6136874-A | Microporous polymeric foams made with silicon or germanium based monomers | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, OSTC | THRB 3131/4885TSHR 3556/4885ALDH1A1 4639/4885 |
| US-20040171859-A1 | Process for stabilizing unsaturated organosilicon compounds | ELOVL1, ELOVL6, DEGS1 | THRB 4533/4885TSHR 4650/4885ALDH1A1 402/4885 |
| US-20260049202-A1 | SILANE COMPOUND AND COMPOSITIONS CONTAINING SAME | ALG3, SNW1, SMURF1 | THRB 4034/4885TSHR 4518/4885ALDH1A1 2065/4885 |
| US-20250109153-A1 | A novel meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, SOST | THRB 3126/4885TSHR 3789/4885ALDH1A1 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.